Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Imagerie cérébrale Oumesmar Zujovic

What causes multiple sclerosis, is it hereditary?

Last update: 29/09/2024 Reading time: 1min

Although multiple sclerosis was described by Charcot more than a century and a half ago, the causes of this disease of the central nervous system are still unknown.

Genetic factors

Genetic factors

Multiple sclerosis (MS) is not an inherited disease. It is a multifactorial condition. Some environmental factors have now been identified without a clear causal relationship. Similarly, genetic predisposition may also be present. The latter can be defined as a combination of genetic variants, which confers a greater risk of developing the disease. It is considered that this alone is not sufficient for the disease to appear, but that it is a breeding ground for its development. It should be noted that most of the genetic variants identified are associated with so-called “immune” genes, that is, genes involved in inflammation.

Environmental factors
Environmental factors

Epidemiological studies have not been able to identify with any certainty an environmental factor responsible for the outbreak of the disease. Vitamin D deficiency could be a triggering factor, but its implication has not yet been conclusively proven. Many viruses have also been studied with the hypothesis that a viral infection acquired in early childhood may cause illness in genetically susceptible individuals.

The link between multiple sclerosis and infection with Epstein-Barr virus has long been suspected. Very recently, an American study has provided important new information on this association. Epstein-Barr virus belongs to the herpes virus family. Mostly contracted asymptomatically in childhood, it is also responsible for infectious mononucleosis or “kissing disease.” The Epstein-Barr virus is widespread in the general population, with an estimated 90% of adults having had contact with the virus. This infection appears to be a necessary but not sufficient condition for the development of multiple sclerosis. The vast majority of the population infected with the Epstein-Barr virus will never develop multiple sclerosis.

No link to vaccination

No link between vaccination and multiple sclerosis

Vaccines have long been implicated in the development of multiple sclerosis (MS) and have been the subject of large-scale epidemiological studies. Two million girls vaccinated against HPV were followed over several years in a study conducted by the National Agency for the Safety of Medicines and Health Products. The conclusion of this study is that the occurrence of multiple sclerosis in these girls is no more frequent than in the general population. Several studies on the relationship between the hepatitis B vaccine and the occurrence of multiple sclerosis have reached the same conclusions.

At Paris Brain Institute

At Paris Brain Institute

The International Multiple Sclerosis Genetics Consortium (IMSGC) involving a research team from Paris Brain Institute published in 2019 a scientific article in the journal Science bringing the number of genetic variants predisposed to multiple sclerosis to 233. The study involved 47,429 patients and 68,374 controls. These findings confirm that multiple sclerosis is the result of a dysfunctional immune system and open the door to functional research into the causes of the disease.
 

Our news on the subject

Neurone de la rétine prolongé par un long axone entouré de sa gaine de myéline. Crédit : Annie Cavanagh, Wellcome collection.
Early cortical remyelination has a neuroprotective effect in multiple sclerosis
Multiple sclerosis is a heterogeneous disease whose manifestations vary considerably from patient to patient and whose course appears, on the surface, unpredictable. Hence, it is crucial to identify the factors that drive disability progression. In a ...
04.02.2024 Research, science & health
sclérose en plaques
Multiple sclerosis: new study highlights five warning signs of the disease
What if the biological mechanisms that cause multiple sclerosis were triggered years before clinical diagnosis? This is what a team at Paris Brain Institute suggests in a new study published in Neurology. The researchers show that, on a population ...
12.06.2023 Research, science & health
Têtard de Xénope transgénique chez lequel la substance blanche (myéline) apparaît par fluorescence, en vert. Crédit : David Akbar (plateforme ICM Quant) et Elodie Martin (Equipe Lubetzki/Stankoff).
Multiple sclerosis: a new tool to reduce clinical failure
No treatment currently exists that can stop the silent progression of multiple sclerosis, and many promising drugs have proved ineffective in clinical trials. To reduce this failure rate and better predict the potential of candidate molecules ...
03.03.2023 Research, science & health
First demonstration of the neuroprotective effect of remyelination in multiple sclerosis patients
First demonstration of the neuroprotective effect of remyelination in multiple sclerosis patients
In an article recently published in the European Journal of Neurology, Vito Ricigliano (AP-HP), Benedetta Bodini (AP-HP/Sorbonne University) and their collaborators at the Paris Brain Institute, demonstrate the protective effect of myelin repair on ...
02.24.2022 Research, science & health
image
New data on inflammation in multiple sclerosis using PET-MRI
Several studies by Prof. Bruno Stankoff's team "Remyelination in multiple sclerosis: from biology to clinical translation", highlight new mechanisms of brain inflammation in multiple sclerosis, thanks to new imaging tools based on the combination of ...
10.20.2021 Research, science & health
Sclérose en plaques et COVID-19
Multiple sclerosis and covid-19
DOES MULTIPLE SCLEROSIS (MS) ALTER THE RISK OF DEVELOPING A SEVERE FORM OF COVID-19 INFECTION? WHAT ARE THE CLINICAL FEATURES AND EFFECTS OF CORONAVIRUS INFECTION IN PATIENTS WITH MS? DO SPECIFIC TREATMENTS FOR SEPSIS INCREASE OR DECREASE THE ...
07.08.2020 Research, science & health
See all our news